MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.
Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.
During her time at MIT, senior Ayesha Ng’s interests have expanded from cellular biology to the social systems that shape public health.
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
A search committee chaired by Institute Professor Phillip Sharp will work to identify a new director for MIT’s pioneering cancer research center.
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.
Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
Regina Barzilay wins $1M Association for the Advancement of Artificial Intelligence Squirrel AI award
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.
Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.